ReVeRa-201 (Completed)
Multi-Centre, Placebo-Controlled, Phase 2 Study of Etripamil Nasal Spray for the Reduction of Ventricular Rate in Patients with Atrial Fibrillation
- Medicine
- Etripamil
- Population
- Arrhythmia
- Phase
- II
- Starting year
- 2022